IL2 and myeloid sarcoma: Higher levels of calpain are expressed in both unactivated and activated PBMCs from MS patients compared to controls, and inhibition of calpain in these cells attenuates secretion of IL-2 and IFNγ, which may promote an anti-inflammatory cytokine bias [89].